Table of contents
Volume 89, Issue 3
Published online 29 July 2003 (425-603)
Minireview |
Tutorial Paper |
Meeting Report |
Clinical |
Epidemiology |
Molecular and Cellular Pathology |
Experimental Therapeutics |
Letters to the Editor
Editorial
Celebrating novel cancer drugs FREE
Robin A Weiss
Br J Cancer 89: 425; doi:10.1038/sj.bjc.6601229
Minireview
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy FREE
S E Duff, C Li, M Jeziorska, S Kumar, M P Saunders, D Sherlock, S T O'Dwyer and G C Jayson
Br J Cancer 89: 426-430; doi:10.1038/sj.bjc.6601145
Tutorial Paper
Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methods FREE
M J Bradburn, T G Clark, S B Love and D G Altman
Br J Cancer 89: 431-436; doi:10.1038/sj.bjc.6601119
Meeting Report
Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK FREE
D R Newell, K M Searle, N B Westwood and S S Burtles on behalf of the Cancer Research UK Phase I/II Clinical Trials Committee
Br J Cancer 89: 437-454; doi:10.1038/sj.bjc.6601106
Clinical
Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin FREE
M A Gonzalez, S Biswas, L Clifton and P G Corrie
Br J Cancer 89: 455-456; doi:10.1038/sj.bjc.6601167
Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? FREE
T Powles, C Thirwell, T Newsom-Davis, M Nelson, P Shah, S Cox, B Gazzard and M Bower
Br J Cancer 89: 457-459; doi:10.1038/sj.bjc.6601111
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients FREE
P Bümming, J Andersson, J M Meis-Kindblom, H Klingenstierna, K Engström, U Stierner, B Wängberg, S Jansson, H Ahlman, L-G Kindblom and B Nilsson
Br J Cancer 89: 460-464; doi:10.1038/sj.bjc.6600965
A medical nutriment has supportive value in the treatment of colorectal cancer FREE
F Jakab, Y Shoenfeld, Á Balogh, M Nichelatti, A Hoffmann, Zs Kahán, K Lapis, Á Mayer, P Sápy, F Szentpétery, A Telekes, L Thurzó, A Vágvölgyi and M Hidvégi
Br J Cancer 89: 465-469; doi:10.1038/sj.bjc.6601153
Treatment of stage 4s neuroblastoma – report of 10 years' experience of the French Society of Paediatric Oncology (SFOP) FREE
G Schleiermacher, H Rubie, O Hartmann, C Bergeron, P Chastagner, F Mechinaud and J Michon for the Neuroblastoma Study Group of the French Society of Paediatric Oncology
Br J Cancer 89: 470-476; doi:10.1038/sj.bjc.6601154
Hypersensitivity reactions related to oxaliplatin (OHP) FREE
G Brandi, M A Pantaleo, C Galli, A Falcone, A Antonuzzo, P Mordenti, M C Di Marco and G Biasco
Br J Cancer 89: 477-481; doi:10.1038/sj.bjc.6601155
Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value FREE
E T Dryver, H Jernström, K Tompkins, R Buckstein and K R Imrie
Br J Cancer 89: 482-486; doi:10.1038/sj.bjc.6601052
Surgeon workload and survival from breast cancer FREE
J Stefoski Mikeljevic, R A Haward, C Johnston, R Sainsbury and D Forman
Br J Cancer 89: 487-491; doi:10.1038/sj.bjc.6601148
Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England FREE
D Robinson, C M J Bell, H Møller and I Basnett
Br J Cancer 89: 492-496; doi:10.1038/sj.bjc.6601149
Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer FREE
J M Blazeby, J Nicklin, S T Brookes, K Winstone and D Alderson
Br J Cancer 89: 497-501; doi:10.1038/sj.bjc.6601146
Epidemiology
Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda FREE
R Newton, J Ziegler, D Bourboulia, D Casabonne, V Beral, E Mbidde, L Carpenter, D M Parkin, H Wabinga, S Mbulaiteye, H Jaffe, R Weiss and C Boshoff The Uganda Kaposi's Sarcoma Study Group
Br J Cancer 89: 502-504; doi:10.1038/sj.bjc.6601113
Incidence of malignant neoplasms among HIV-infected persons in Scotland FREE
G M Allardice, D J Hole, D H Brewster, J Boyd and D J Goldberg
Br J Cancer 89: 505-507; doi:10.1038/sj.bjc.6601139
Survival from breast cancer among South Asian and non-South Asian women resident in South East England FREE
I dos Santos Silva, P Mangtani, B L De Stavola, J Bell, M Quinn and D Mayer
Br J Cancer 89: 508-512; doi:10.1038/sj.bjc.6601097
Epidemiologic and molecular risk factors for contralateral breast cancer among young women FREE
C I Li, K E Malone, P L Porter and J R Daling
Br J Cancer 89: 513-518; doi:10.1038/sj.bjc.6601042
A meta-analysis of obesity and the risk of pancreatic cancer FREE
A Berrington de Gonzalez, S Sweetland and E Spencer
Br J Cancer 89: 519-523; doi:10.1038/sj.bjc.6601140
Molecular and Cellular Pathology
Suppressor of cytokine signalling gene expression is elevated in breast carcinoma FREE
M Raccurt, S P Tam, P Lau, H C Mertani, A Lambert, T Garcia-Caballero, H Li, R J Brown, M A McGuckin, G Morel and M J Waters
Br J Cancer 89: 524-532; doi:10.1038/sj.bjc.6601115
CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer FREE
B J Coventry and J Morton
Br J Cancer 89: 533-538; doi:10.1038/sj.bjc.6601114
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer FREE
J-Y Pierga, C Bonneton, H Magdelénat, A Vincent-Salomon, C Nos, P Pouillart and J-P Thiery
Br J Cancer 89: 539-545; doi:10.1038/sj.bjc.6601121
Association between RCAS1 expression and clinical outcome in uterine endometrial cancer FREE
K Sonoda, S Miyamoto, T Hirakawa, T Kaku, M Nakashima, T Watanabe, K Akazawa, T Fujita and H Nakano
Br J Cancer 89: 546-551; doi:10.1038/sj.bjc.6601126
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer FREE
J Edwards, N S Krishna, K M Grigor and J M S Bartlett
Br J Cancer 89: 552-556; doi:10.1038/sj.bjc.6601127
Expression of E-cadherin, 
-catenin, and 
-catenin in the process of lymph node metastasis in oral squamous cell carcinoma FREE
N Tanaka, T Odajima, K Ogi, T Ikeda and M Satoh
Br J Cancer 89: 557-563; doi:10.1038/sj.bjc.6601124
Ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in oesophageal cancer cells: involvement of the p38MAPK signalling pathway FREE
A P Sutter, K Maaser, B Barthel and H Scherübl
Br J Cancer 89: 564-572; doi:10.1038/sj.bjc.6601125
Experimental Therapeutics
Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells FREE
D N Wheatley and E Campbell
Br J Cancer 89: 573-576; doi:10.1038/sj.bjc.6601134
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts FREE
B Geoerger, J Grill, P Opolon, J Morizet, G Aubert, Y Lecluse, V W van Beusechem, W R Gerritsen, D H Kirn and G Vassal
Br J Cancer 89: 577-584; doi:10.1038/sj.bjc.6601102
Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil FREE
N Magné, J-L Fischel, C Tiffon, P Formento, A Dubreuil, N Renée, J-L Formento, M Francoual, J Ciccolini, M-C Etienne and G Milano
Br J Cancer 89: 585-592; doi:10.1038/sj.bjc.6601131
Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks FREE
R A El-Awady, E Dikomey and J Dahm-Daphi
Br J Cancer 89: 593-601; doi:10.1038/sj.bjc.6601133
Letters to the Editor
Smoking and hepatoblastoma: confounding by birth weight? FREE
L G Spector and J A Ross
Br J Cancer 89: 602; doi:10.1038/sj.bjc.6601143
Reply: Smoking and hepatoblastoma: confounding by birth weight? FREE
D Pang and J M Birch
Br J Cancer 89: 603; doi:10.1038/sj.bjc.6601144
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
